Supplemental material
Hematology
Volume 27, 2022 - Issue 1
Open access
2,518
Views
1
CrossRef citations to date
0
Altmetric
Research Article
Validation and reliability of current guidelines for the treatment of essential thrombocythemia under real-world clinical settings in Japan
Terumi Babaa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Yoshinori Hashimotoa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;b Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Hajime Yasudaa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Marito Arakib Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Yoko Edahiroa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;b Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Soji Morishitab Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Tomonori Ochiaia Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;b Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Shuichi Shiranea Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;b Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Jun Andoa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Department of Transfusion Medicine and Stem Cell Regulation, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
& Norio Komatsua Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;b Laboratory for the Development of Therapies Against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanCorrespondence[email protected]
View further author information
show allView further author information
Pages 157-166
|
Published online: 24 Jan 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.